Sanofi holds targets despite profit slip, shares plunge

French drugmaking group Sanofi reported on Tuesday that net profit slipped in the third quarter but that its main treatments were doing well and research for new drugs including a dengue fever vaccine looked promising. Chief executive Christopher Viehbacher, the target of criticism because he has based himself in Boston in the United States to run the group, said "we are pleased with our performance in the third quarter", and this enabled the group to "confirm out 2014 outlook".

via Health News Headlines - Yahoo News http://ift.tt/1syn6s5